Brandon successfully led the design, development and scaling of Medcura's manufacturing capabilities for the  first commercial medical device under cGMP and ISO 13485. By leveraging years of experience and deep foundational knowledge regarding Medcura's biomaterial platform, Brandon has implemented a robust cGMP process for the Company's biosurgical program (during a global supply chain crisis). Brandon joined Medcura after earning his BS in Chemical and Biomolecular Engineering from the University of Maryland (College Park , MD), where he specialized in targeted and controlled-release drug delivery systems, as well as polymer synthesis for advanced medical devices.

‍